Bank Julius Baer & Co’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,000
Closed -$41K 853
2021
Q3
$41K Buy
1,000
+9
+0.9% +$376 ﹤0.01% 693
2021
Q2
$45K Sell
991
-9
-0.9% -$398 ﹤0.01% 687
2021
Q1
$42K Sell
1,000
-7
-0.7% -$320 ﹤0.01% 682
2020
Q4
$43K Sell
1,007
-193
-16% -$6.94K ﹤0.01% 699
2020
Q3
$32K Hold
1,200
﹤0.01% 637
2020
Q2
$32K Buy
+1,200
New +$27.1K ﹤0.01% 592

Other funds holding HALO

Bank Julius Baer & Co's HALO Position: Q4 2021 in Review

Bank Julius Baer & Co sold out of Halozyme (HALO) in Q4 2021, closing a stake of 1,000 shares — an estimated $41K sold.

Bank Julius Baer & Co first reported a position in HALO in Q2 2020 and held it in 6 quarters. The position peaked at $45K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • Bank Julius Baer & Co reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,000 Halozyme shares in Q4 2021, an estimated $41K.
  • Bank Julius Baer & Co first reported a position in Halozyme in Q2 2020 and held it in 6 quarters.
  • Bank Julius Baer & Co's Halozyme position peaked at $45K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Bank Julius Baer & Co's 13F filing for Q4 2021, filed 15 Feb 2022.